Chemoreflexes, sleep apnea, and sympathetic dysregulation

Area of Science:

• Cardiovascular Physiology
• Sleep Medicine
• Autonomic Nervous System

Background:

• Obstructive sleep apnea (OSA) and hypertension are frequently comorbid conditions.
• Disordered breathing during sleep in OSA triggers sympathetic nervous system activation.
• This sustained sympathetic activation contributes to hypertension and adverse cardiovascular outcomes.

Purpose of the Study:

• To review the physiological mechanisms linking obstructive sleep apnea and hypertension.
• To discuss the role of chemoreflexes and sympathetic dysregulation in OSA.
• To examine the impact of OSA on autonomic balance and cardiovascular health.

Main Methods:

• Review of existing literature on chemoreflex physiology and sympathetic modulation in sleep.
• Analysis of evidence for peripheral chemoreflex involvement in OSA-related sympathetic dysregulation.
• Discussion of cardiovascular variability and other mechanisms in OSA autonomic imbalance.

Main Results:

• Hypoxemia during OSA activates chemoreflexes, increasing sympathetic neural outflow.
• Apnea potentiates central sympathetic outflow, with activation persisting into wakefulness.
• Peripheral chemoreflex plays a significant role in sympathetic dysregulation in OSA, especially with comorbidities.

Conclusions:

• Sympathetic overactivation, driven by chemoreflexes and breathing disturbances in OSA, is a key mechanism linking OSA to hypertension.
• Understanding these pathways is crucial for managing cardiovascular risks in OSA patients.
• Further research into autonomic imbalance and cardiovascular variability in OSA is warranted.